Skip to main content
. 2021 Aug 2;12(1):4757–4767. doi: 10.1080/21655979.2021.1954581

Figure 8.

Figure 8.

By use of molecular docking analysis, bio-structurally binding capability of metformin with target proteins in obesity/hypertension, including IL-6, CCL2, was identified and demonstrated